Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.30 |
| ▸ | ACACA | Q13085 | 1/20 | 0.30 |
| ▸ | F9 | P00740 | 1/20 | 0.30 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17307433 | 0.99 | ALOX5 (0.37) | ALOX5MAPTRARBRARGRXRA | |
| SCHEMBL17307441 | 0.93 | ALOX5 (0.38) | ALOX5MAPTRARBRARGRXRA | |
| SCHEMBL17307444 | 0.93 | ALOX5 (0.37) | ALOX5MAPTATMTNKSTNKS2 | |
| SCHEMBL17307450 | 0.93 | ALOX5 (0.37) | ALOX5MAPTATMTNKSTNKS2 | |
| SCHEMBL17307436 | 0.92 | ALOX5 (0.38) | ALOX5MAPTATMTNKSTNKS2 | |
| SCHEMBL17307432 | 0.92 | ALOX5 (0.38) | ALOX5MAPTATMTNKSTNKS2 | |
| SCHEMBL17307409 | 0.92 | MEN1 (0.35) | ALOX5MAPTMEN1TSHRKMT2A | |
| SCHEMBL17307421 | 0.91 | MEN1 (0.34) | ALOX5MAPTMEN1TSHRKMT2A | |
| SCHEMBL17307457 | 0.90 | MEN1 (0.36) | ALOX5MAPTMEN1TSHRKMT2A | |
| SCHEMBL17307452 | 0.90 | ALOX5 (0.42) | ALOX5MAPTRARBRARGRXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9653690-B2 | Organic compound, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2017-05-16 | — | — | US | disclosed |
| US-9653690-B2 | Organic compound, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2017-05-16 | — | — | US | disclosed |
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OXER1, OR10J3 | ALOX5 798/4885MAPT 2444/4885RARB 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.